Leniolisib phosphate

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameLeniolisib phosphate
Drug Alias Nameleniolisib莱尼利塞leniolisibum来尼利司JOENJA +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitors
TargetsPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsActivated PI3K-delta syndromeCommon Variable ImmunodeficiencyImmunologic Deficiency Syndromes +[6] 
Global Approved IndicationsActivated PI3K-delta syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/03/24
Country/TerritoryCzechiaUnited StatesPortugal +[15] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesOrphanpacificPharming Technologies BvNovartis Pharma Ag +[4] 
Inactive CompaniesN/A
Active IndicationsActivated PI3K-delta syndromeCommon Variable ImmunodeficiencyImmunologic Deficiency Syndromes +[5] 
Inactive IndicationsSjogren's Syndrome

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG